Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

WGS - GeneDx Holdings Corp.

IEX Last Trade
78.97
0.850   1.076%

Share volume: 6,824
Last Updated: Thu 26 Dec 2024 08:30:24 PM CET

PREVIOUS CLOSE
CHG
CHG%
$78.12
0.85
1.09%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.31%
1 Month
-3.87%
3 Months
90.55%
6 Months
195.53%
1 Year
2,446.05%
2 Year
31,699.51%
Key data
Stock price
$78.97
P/E Ratio 
-7.33
DAY RANGE
$77.79 - $81.21
EPS 
-$3.79
52 WEEK RANGE
$2.71 - $89.11
52 WEEK CHANGE
$2,704.35
MARKET CAP 
860.333 M
YIELD 
N/A
SHARES OUTSTANDING 
26.936 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/28/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$579,614
AVERAGE 30 VOLUME 
$503,585
Company detail
CEO: Katherine A. Stueland
Region: US
Website: sema4.com
Employees: 1,200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Sema4 Holdings Corp. operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle.

Recent news